Evommune, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of EVO756 in Adults With Migraine (NCT07616128) | Evommune, Inc. | 2026-07-29 |
| Phase 2b Study of EVO756 in Adults With Atopic Dermatitis (NCT07150845) | Evommune, Inc. | 2025-08-26 |
| Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) (NCT06873516) | Evommune, Inc. | 2025-03-20 |
| Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis (NCT06723405) | Evommune, Inc. | 2025-02-13 |
| A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria (NCT06603220) | Evommune, Inc. | 2024-08-14 |
| Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis (NCT05579899) | Evommune, Inc. | 2022-09-27 |
Track Evommune, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.